5. 進行性核上性麻痺 Progressive supranuclear palsy Clinical trials / Disease details

臨床試験数 : 89 / 薬物数 : 107 - (DrugBank : 40) / 標的遺伝子数 : 65 - 標的パスウェイ数 : 108

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05187546 (ClinicalTrials.gov)	March 10, 2022	23/11/2021	Test-retest Study With [18F]PI-2620 in PSP-RS and NDC	An Open Label, Single Center Study to Evaluate the Safety and Test-retest Characteristics of [18F]PI ...	Progressive Supranuclear Palsy	Drug: [18F]-PI2620	Life Molecular Imaging GmbH	NULL	Recruiting	50 Years	80 Years	All	15	Phase 1	Germany
2	NCT04715750 (ClinicalTrials.gov)	November 12, 2020	11/12/2020	Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low ...	An Open Label, Single Center Study to Evaluate the Safety and Imaging Characteristics of [18F]PI-262 ...	Alzheimer Disease;Progressive Supranuclear Palsy	Drug: [18F]-PI2620	Life Molecular Imaging GmbH	Life Molecular Imaging SA	Active, not recruiting	50 Years	80 Years	All	10	Phase 1	Germany

First Previous1Next Last